All Stories

  1. Retraction notice for: “Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases.” Theodoros V. Giannouchos, Roberto A. Sussman, José M. Mier, Konstantinos Poulas ...
  2. COVID-19 and the nicotinic cholinergic system
  3. Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys
  4. Metal emissions from e-cigarettes: a risk assessment analysis of a recently-published study
  5. Electronic cigarettes: an aid in smoking cessation, or a new health hazard?
  6. Nicotine delivery to the aerosol of a heat-not-burn tobacco product: comparison with a tobacco cigarette and e-cigarettes.
  7. Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey
  8. Endothelial progenitor cell release is usually considered a beneficial effect: Problems in interpreting the acute effects of e-cigarette use
  9. E-cigarette use in the European Union: millions of smokers claim e-cigarettes helped them quit
  10. Comment on “Flavoring Compounds Dominate Toxic Aldehyde Production during E Cigarette Vaping”
  11. Introduction to e-Cigarettes
  12. Review of Compounds of Regulatory Concern
  13. Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries
  14. Harmful effects from one puff of shisha-pen vapor: methodological and interpretational problems in the risk assessment analysis
  15. Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic Cigarettes among Healthcare Professionals in Greece
  16. Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: regulatory implications
  17. E-Cigarette as a Harm Reduction Approach among Tobacco Smoking Khat Chewers: A Promising Bullet of Multiple Gains
  18. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes
  19. Electronic cigarette experimentation in the Malaysian city of Kuantan: Was there an association with the smoking status?
  20. Survival from inpatient cardiac arrest in a specialised referral hospital for Cardiology and Cardiac Surgery
  21. Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors
  22. Response to Shihadeh et al . (2015): E‐cigarettes generate high levels of aldehydes only in ‘dry puff’ conditions
  23. E-cigarettes need to be tested for safety under realistic conditions
  24. Research letter on e-cigarette cancer risk was so misleading it should be retracted
  25. Erratum: Corrigendum: Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers)
  26. Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes)
  27. Tobacco-Specific Nitrosamines in Electronic Cigarettes: Comparison between Liquid and Aerosol Levels
  28. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers)
  29. Apical traction: a novel visual echocardiographic parameter to predict survival in patients with pulmonary hypertension
  30. Factors associated with dual use of tobacco and electronic cigarettes: A case control study
  31. E-cigarettes generate high levels of aldehydes only in ‘dry puff’ conditions
  32. Are Metals Emitted from Electronic Cigarettes a Reason for Health Concern? A Risk-Assessment Analysis of Currently Available Literature
  33. Toxicity Assessment of Refill Liquids for Electronic Cigarettes
  34. Nicotine Levels and Presence of Selected Tobacco-Derived Toxins in Tobacco Flavoured Electronic Cigarette Refill Liquids
  35. Why We Consider the NIOSH-Proposed Safety Limits for Diacetyl and Acetyl Propionyl Appropriate in the Risk Assessment of Electronic Cigarette Liquid Use: A Response to Hubbs et al.
  36. Asking the wrong questions about e-cigarettes? A response to Stan Shatenstein
  37. A critique of a World Health Organization-commissioned report and associated paper on electronic cigarettes
  38. Risks of Attempting to Regulate Nicotine Flux in Electronic Cigarettes
  39. Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins
  40. Youth Tobacco Use and Electronic Cigarettes
  41. Cytotoxicity of cinnamon-flavored electronic cigarette refills: Are the results truly applicable to electronic cigarette use?
  42. E-cigarette use and indoor air quality: Methodological limitations
  43. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes
  44. Comment on E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism
  45. Survival from inpatient cardiac arrest in a tertiary referral hospital for Cardiology and Cardiothoracic Surgery
  46. Is there any legal and scientific basis for classifying electronic cigarettes as medications?
  47. Characteristics, Perceived Side Effects and Benefits of Electronic Cigarette Use: A Worldwide Survey of More than 19,000 Consumers
  48. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review
  49. It is preferable for surgical patients to use e-cigarettes rather than smoke cigarettes
  50. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices
  51. Impact of Flavour Variability on Electronic Cigarette Use Experience: An Internet Survey
  52. Comparison of the Cytotoxic Potential of Cigarette Smoke and Electronic Cigarette Vapour Extract on Cultured Myocardial Cells
  53. Authors miss the opportunity to discuss important public health implications
  54. Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ Regulation
  55. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract
  56. Chronic Idiopathic Neutrophilia in A Smoker, Relieved after Smoking Cessation with the Use of Electronic Cigarette: a Case Report
  57. Acute and Chronic Effects of Smoking on Myocardial Function in Healthy Heavy Smokers: A Study of Doppler Flow, Doppler Tissue Velocity, and Two-Dimensional Speckle Tracking Echocardiography
  58. Survival from inpatient cardiac arrest in a specialised referral hospital
  59. DELAYED LEFT VENTRICULAR RELAXATION DUE TO SMOKING IN HEALTHY SUBJECTS: A STRAIN-IMAGING STUDY
  60. COMPARISON OF KNOWLEDGE LEVEL ABOUT ANTICOAGULATION THERAPY BETWEEN ATRIAL FIBRILLATION AND PROSTHETIC HEART VALVE PATIENTS AND ITS' RELATION TO INR GOAL ATTAINMENT